News | March 28, 2024
Asahi Songwon Colors acquires remaining 22% stake in Atlas Life Sciences
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
To accelerate the development of next-generation radioconjugates to treat cancer
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Subscribe To Our Newsletter & Stay Updated
